| |
| |
|
| Insider
Information: |
Dahan Michel |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
672,092 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$752,743 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
672,092 |
|
|
| Total
Value |
$752,743 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
10
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
7
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -303.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Akebia Therapeutics, Inc. |
AKBA |
|
2024-05-13 |
672,092 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Operating Officer |
• – – |
2024-05-13 |
4 |
AS |
$1.26 |
$43,898 |
D/D |
(34,840) |
672,092 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Operating Officer |
• – – |
2024-02-29 |
4 |
S |
$1.58 |
$13,684 |
D/D |
(8,661) |
706,932 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Operating Officer |
• – – |
2024-02-27 |
4 |
S |
$1.52 |
$16,331 |
D/D |
(10,744) |
715,593 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Operating Officer |
• – – |
2024-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
149,300 |
726,337 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Operating Officer |
• – – |
2023-05-25 |
4 |
S |
$1.22 |
$116,760 |
D/D |
(95,478) |
574,037 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Operating Officer |
• – – |
2023-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
669,515 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Operating Officer |
• – – |
2023-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
469,515 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Operating Officer |
• – – |
2023-03-01 |
4 |
S |
$0.88 |
$17,912 |
D/D |
(20,412) |
269,515 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Operating Officer |
• – – |
2023-02-27 |
4 |
S |
$0.81 |
$8,205 |
D/D |
(10,090) |
289,927 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Operating Officer |
• – – |
2022-03-01 |
4 |
S |
$2.17 |
$32,513 |
D/D |
(14,978) |
297,017 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Operating Officer |
• – – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
308,995 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Operating Officer |
• – – |
2022-02-28 |
4 |
S |
$2.15 |
$14,125 |
D/D |
(6,555) |
258,995 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Operating Officer |
• – – |
2021-04-01 |
4 |
S |
$3.40 |
$4,117 |
D/D |
(1,211) |
265,550 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Operating Officer |
• – – |
2021-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
11,648 |
266,761 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Operating Officer |
• – – |
2021-03-01 |
4 |
S |
$3.40 |
$49,403 |
D/D |
(14,547) |
255,113 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Operating Officer |
• – – |
2021-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
62,000 |
269,660 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Operating Officer |
• – – |
2020-02-28 |
4 |
S |
$8.70 |
$60,656 |
D/D |
(6,972) |
204,960 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Operating Officer |
• – – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
211,932 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Business Officer |
• – – |
2019-04-11 |
4 |
D |
$7.70 |
$91,699 |
D/D |
(11,909) |
146,932 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Business Officer |
• – – |
2019-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
158,841 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Business Officer |
• – – |
2018-12-12 |
4 |
D |
$8.94 |
$209,062 |
D/D |
(23,385) |
93,841 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Business Officer |
• – – |
2018-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
19,400 |
115,226 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Business Officer |
• – – |
2017-10-02 |
4 |
AS |
$19.64 |
$27,457 |
D/D |
(1,398) |
95,826 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Business Officer |
• – – |
2017-09-28 |
4 |
AS |
$19.30 |
$96,500 |
D/D |
(5,000) |
97,224 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Business Officer |
• – – |
2017-08-15 |
4 |
AS |
$15.00 |
$75,000 |
D/D |
(5,000) |
102,224 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
